irinotecan has been researched along with ozone in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 3 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Gu, Y; He, X; Hu, L; Li, Y; Liu, WT; Liu, X; Wang, C; Yang, X; Yu, Q; Zhang, C; Zhang, X | 1 |
| Akira, K; Funahashi, T; Hatae, N; Hidaka, N; Kato, G; Maki, T; Mitome, H; Sasaki, Y; Shigematsu, S; Shimasaki, M; Tanabe, T; Tanaka, M; Utsunomiya, A; Yamamoto, H | 1 |
| Figueiredo Martins, A; Mello Souza, D; Ramos do Nascimento, V; Reichert, JF | 1 |
3 other study(ies) available for irinotecan and ozone
| Article | Year |
|---|---|
AMPK activation by ozone therapy inhibits tissue factor-triggered intestinal ischemia and ameliorates chemotherapeutic enteritis.
Topics: Aged; AMP-Activated Protein Kinases; Animals; Disease Models, Animal; Enteritis; Female; Humans; Intestinal Mucosa; Irinotecan; Male; Mice; Middle Aged; Ozone; Reperfusion Injury; Thromboplastin | 2020 |
Degradation and inactivation efficacy of ozone water for antineoplastic drugs in hospital settings.
Topics: Antineoplastic Agents; Hospitals; Humans; Irinotecan; Mutagens; Ozone; Paclitaxel; Pharmaceutical Preparations; Water | 2022 |
Ozonation and UV photolysis for removing anticancer drug residues from hospital wastewater.
Topics: Antineoplastic Agents; Epirubicin; Hospitals; Irinotecan; Oxidation-Reduction; Ozone; Photolysis; Ultraviolet Rays; Wastewater; Water Pollutants, Chemical; Water Purification | 2022 |